Pacritinib is an oral kinase inhibitor primarily used to treat hematological malignancies such as myelofibrosis. This drug targets the JAK2/FLT...
Pacritinib has shown significant efficacy in the treatment of hematological malignancies such as myelofibrosis, especially in patients with t...
Canaglu hydrochloride is a urinary tract anti infective drug targeting the METAP2 target, mainly used to treat urinary tract infections caused ...
The conventional dose of Canaglu hydrochloride is 1-3 pills per day, and the specific dosage needs to be adjusted according to the indications....
Quizartinib is an FLT3 tyrosine kinase inhibitor mainly used to treat specific types of acute myeloid leukemia. Its standard dose needs to be a...
Quizartinib, as an FLT3 inhibitor, commonly has side effects including hematological toxicity, prolonged cardiac QT interval, and gastrointesti...
The recommended dose of Ceritinib is once daily oral administration of 450mg, which should be taken with meals to optimize absorption. The clin...
Encorafenib is a targeted therapy drug mainly used for melanoma, colorectal cancer, and non-small cell lung cancer with specific gene mutations...
Encorafenib, as a BRAF inhibitor, commonly has side effects such as skin reactions, bleeding tendency, and cardiac toxicity. Dosage adjustments...